Bausch+Lomb Results Presentation Deck

Segment Financials Vision Care Contact Lens Revenue Consumer Revenue Total Revenue Surgical Implantables Revenue Equipment Revenue Consumables Revenue Total Revenue Ophthalmic Pharmaceuticals Total Revenue BAUSCH + LOMB 2Q22 $213M $376M $589M 2Q22 $50M $34M $100M $184M 2Q22 $168M 1. This is a non-GAAP measure or ratio. See Slide 2 and this Appendix for further information on non-GAAP measures and ratios. 2Q21 $216M $340M $556M 2Q21 $48M $40M $97M $185M 2Q21 $193M Reported Change (1%) 11% 6% Reported Change 4% (15%) 3% (1%) Reported Change (13%) Organic Change %¹ 5% 15% 11% Organic Change %¹ 10% (10%) 13% 7% Organic Change %¹ (10%) 27

View entire presentation